Last reviewed · How we verify

NCT06365554

On-Premise and Remote Robotic Neurointervention

Not yet recruiting NA Last updated 15 April 2024
What this trial tests

NA trial testing Remedy Robot in Cerebrovascular Disease in 10 participants. Not yet recruiting.

Timeline
1 June 2024
Primary endpoint
1 January 2025
1 June 2025

Quick facts

Lead sponsorRemedy Robotics, Inc.
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment10
Start date1 June 2024
Primary completion1 January 2025
Estimated completion1 June 2025

Drugs / interventions tested

Conditions studied

Sponsor

Remedy Robotics, Inc.

Who can join

18 and older, any sex, with Cerebrovascular Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective, single arm, single-center study to evaluate the safety and feasibility of the Remedy Robot for on premise and remote robotic Neurointervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cerebrovascular Disease

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06365554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing